PHA Scientific Leadership Council

PHA’s Scientific Leadership Council (SLC) is composed of leaders in the field of pulmonary hypertension (PH). Coordinating the medical arm of PHA, they provide medical and scientific leadership and guidance for the mission of PHA and lead the development of the wide array of PHA’s medical programming.

SLC members proactively facilitate the development of new knowledge about PH, develop educational resources for medical and public audiences, and advocate to raise awareness about pulmonary hypertension (PH). The SLC was formed out of the PHA philosophy that patients and medical professionals can achieve more working together.

Members of the SLC are clinicians and researchers recognized for performing outstanding research and providing excellent care for people living with PH.

Members of the Scientific Leadership Council (SLC) serve as PHA’s medical leadership and are cardiologists, pulmonologists and rheumatologists – leading PH experts that branch out into all areas of scientific exploration and treatment of pulmonary hypertension (PH). Not only do they guide the vast array of medical education PHA offers to both the medical and patient communities, they also are involved in the development of cutting-edge research exploring various aspects of PH such as the implications of genetics in pulmonary hypertension, treatments for children living with PH, PH and associated diseases and much more.

Many past and present members of the SLC are involved in authoring or editing Advances in Pulmonary Hypertension, the Official Journal of the Pulmonary Hypertension Association, in developing patient education materials or planning/speaking at patient education events, in planning or serving as faculty at continuing medical education (CME) activities, and in creating the comprehensive treatment fact sheets and consensus statements available on our website.

Individuals invited to serve on the SLC are known for their contributions in the PH field – in research and in providing quality care to people living with PH as well as for their volunteerism in the PH community through PHA. They represent PH centers and clinics in urban and rural areas, in large hospital systems and private practices.

PHA Scientific Leadership Council Members

Murali M. Chakinala, MDMurali M. Chakinala, M.D., FCCP
SLC Chair
Professor of Medicine
Washington University School of Medicine
Division of Pulmonary and Critical Care
St. Louis, Mo.
Term Ends June 2024

Anna R. Hemnes, M.D.
SLC Chair-Elect

Associate Professor of Medicine
Assistant Director, Pulmonary Vascular Center
Vanderbilt University Medical Center
Nashville, Tenn.
Term Ends June 2026

Ronald J. Oudiz, M.D.
SLC Immediate Past Chair
Professor of Medicine
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institute at Harbor – UCLA Medical Center
Torrance, Calif.
Term Ends June 2022

Committees

Research Committee

Todd M. Bull, M.D.
Chair, Research Committee

Professor of Medicine
Director, Pulmonary Vascular Disease Center
Director, Comprehensive Lung and Breathing Program
Associate Head of Clinical Affairs
Pulmonary Sciences and Critical Care Medicine and Cardiology
University of Colorado
Denver, Colo.

Members of the Research Committees are leading researchers in the field of pulmonary hypertension. They guide the growth and development of PHA’s Research Program.

Mission Statement and Charge

The Research Committee of the Scientific Leadership Counsel was created to support PHA in its mission to advance PH research in the field for both patient and professional populations. In order to grow the research opportunities, information and resources available to these communities, the Research Committee is charged with supporting the following activities:

  • The Research Committee will advance the goals of the PHA to become a funding body for new research initiatives.
  • The Research Committee will encourage the development of new PH research and researchers through mentorship by established research leaders in the field who will recruit and lead newer researchers.

The Research Committee will commence periodically to discuss progress, evaluate goals and plan.

Todd Bull, M.D. 
Chair, Research Committee
Associate Professor of Medicine
University of Colorado
Aurora, Colo.

Steven H. Abman, M.D.
Professor, Department of Pediatrics
Director, Pediatric Heart Lung Center
University of Colorado School of Medicine
Children’s Hospital Colorado
Aurora, Colo.

Eric D. Austin, M.D., MSCI
Associate Professor of Pediatrics
Director, Vanderbilt Pediatric Pulmonary Hypertension Program
Vanderbilt University Medical Center
Nashville, Tenn.

Karen A. Fagan, M.D.
Associate Professor of Medicine
Chief of Pulmonology, Critical Care
University of South Alabama
Mobile, Ala.

Matthew R. Lammi, M.D.
Associate Professor of Medicine
Louisiana State University
New Orleans

Vinicio A. de Jesus Perez, M.D.
Assistant Professor of Medicine
Stanford University
Stanford, Calif.

Education Committee

Lana Melendres-Groves, M.D.
Chair, Education Committee

Medical Director, Pulmonary Hypertension Program
Associate Professor, Dept. of Internal Medicine
Pulmonary & Critical Care Division
University of New Mexico
Albuquerque, N.M.

The Education Committee provides guidance in the development of patient educational material such as the Patients Survival Guide, develops current information on the latest treatments and devises consensus statements on different aspects of living with pulmonary hypertension.

Mission Statement and Charge

The Education Committee of the Scientific Leadership Council was created to support PHA in its mission to advance PH education in the field for both patient and professional populations. In order to grow the educational opportunities, information and resources available to these communities, the Education Committee is charged with the following activities:

  • The Education Committee will facilitate education through the development of practice consensus statements and treatment fact sheets.
  • The Education Committee will actively work with the PHPN to develop educational materials for patients and caregivers as well as PH-treating health care professionals.
  • The Education Committee will support the goals of the PHA Medical Education Fund and the PHA Community PH Education Fund.

Lana Melendres-Groves, M.D.
Chair, Education Committee

Medical Director, Pulmonary Hypertension Program
Associate Professor, Dept. of Internal Medicine
Pulmonary & Critical Care Division
University of New Mexico
Albuquerque, N.M.

Sonja BartolomeM.D.
Director of Liver Transplant Critical Care
Associate Professor, Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Michael J. Cuttica, M.D., M.S.
Associate Professor of Medicine
Northwestern University
Chicago

Jeffrey Fineman, M.D.
Pediatric Critical Care Specialist
Critical Care Division Chief
University of California, San Francisco
Benioff Children’s Hospital
San Francisco

Mardi Gomberg-MaitlandM.D., M.Sc.
Professor of Medicine, VCU School of Medicine
Director of RV Failure, HFpEF and Cardio-Oncology Programs
Co-Director of the Pulmonary Vascular Disease Program
Inova Heart and Vascular Institute
Falls Church, Va.

David C. Ishizawar, M.D.
Associate Professor
Froedtert & the Medical College of Wisconsin
Milwaukee

Adolfo Kaplan, M.D.
Associate Director
Pulmonary & Sleep Center of The Valley
McAllen, Texas

Jamie L. W. Kennedy, M.D., FACC
Assistant Professor
Advanced Heart Failure and Transplant Cardiology
Medical Director, Coronary Care Unit and Pulmonary Hypertension Center
University of Virginia
Charlottesville, Va.

John J. Ryan, M.D.
Director, Pulmonary Hypertension Center
University of Utah
Salt Lake City, Utah

Namita SoodM.D.
Associate Professor, Pulmonary, Allergy, Critical Care & Sleep
Ohio State University, Wexner Medical Center
Columbus, Ohio

Corey E. Ventetuolo, M.D., M.S.
Assistant Professor of Medicine and Health Services, Policy, and Practice, The Warren Alpert Medical School of Brown University
Associate Director, Pulmonary Hypertension Center
Medical Director, Adult Extracorporeal Life Support Program
Director of Clinical Research, Pulmonary Division
Rhode Island Hospital
Providence, R.I.

Loida A. Johnson, CRNP,
Chair, PHPN Education Committee
Nurse Practitioner, Pulmonary Hypertension Program
University of Maryland Medical Center
Baltimore, Md.

Members

Steven H. Abman, M.D.
Professor, Department of Pediatrics
Director, Pediatric Heart Lung Center
University of Colorado School of Medicine
Children’s Hospital Colorado
Aurora, Colo.
Term Ends June 2023

William R. Auger, M.D.
Clinical Professor of Medicine
Lewis Katz School of Medicine at Temple University
Physician, Pulmonary Hypertension, Right Heart Failure and CTEPH Program
Temple Heart and Vascular Institute
Philadelphia, Pa.
Term Ends June 2023

Eric D. Austin, M.D., MSCI
Associate Professor of Pediatrics
Director, Vanderbilt Pediatric Pulmonary Hypertension Program
Vanderbilt University Medical Center
Nashville, Tenn.
Term Ends June 2023

Sonja Bartolome, M.D.
Associate Professor, Internal Medicine
Director, Liver Transplant Critical Care
University of Texas Southwestern Medical Center
Dallas, Texas
Term Ends June 2021

Todd M. Bull, M.D.
Professor of Medicine
Director, Pulmonary Vascular Disease Center
Director, Comprehensive Lung and Breathing Program
Associate Head of Clinical Affairs
Pulmonary Sciences and Critical Care Medicine and Cardiology
University of Colorado
Denver, Colo.
Term Ends June 2023

Kelly Chin, M.D.
Associate Professor, Internal Medicine
Director, Pulmonary Hypertension Program
UT Southwestern Medical Center
Dallas, Texas
Term Ends June 2023

Vinicio A. de Jesus Perez, M.D., FCCP, FAHA, ATSF
Associate Professor of Medicine
Co-Director, Stanford Translational Investigator Program
Stanford Adult Pulmonary Hypertension Clinic
Stanford University Medical Center
Stanford, Calif.
Terms Ends June 2021

Teresa De Marco, M.D.
Director of Advanced Heart Failure and Pulmonary Hypertension
Medical Director of Heart Transplantation
University of California, San Francisco
San Francisco, Calif.
Term Ends June 2022

Ankit A. Desai, M.D., FACC, FAHA
Associate Professor of Medicine
Krannert Institute of Cardiology
Indiana University
Indianapolis, Ind.
Term Ends June 2021

Jeffrey R. Fineman, M.D.
Pediatric Critical Care Specialist
Critical Care Division Chief
University of California, San Francisco
Benioff Children’s Hospital
San Francisco. Calif.
Term Ends June 2021

Robert P. Frantz, M.D.
Director, Pulmonary Hypertension Clinic
Professor of Medicine
Mayo Clinic
Rochester, Minn.
Term Ends June 2021

Mardi Gomberg-Maitland, M.D., M.Sc.
Director of the Pulmonary Hypertension Program
Medical Faculty Associates, George Washington University, Heart and Vascular Institute
Washington, D.C.
Term Ends June 2022

Kristin B. Highland, M.D., MSCR
Staff Physician, Pulmonary and Rheumatology Departments
Director, Rheumatic Lung Disease Program
Cleveland Clinic
Cleveland, Ohio
Term Ends June 2023

Steven Kawut, M.D., M.S.
Professor of Medicine and Epidemiology
Director, Pulmonary Vascular Disease Program
Perelman School of Medicine at the University of Pennsylvania
Philadelphia
Term Ends June 2022

Tim Lahm, M.D.
Associate Professor of Medicine and Cellular & Integrative Physiology
Division of Pulmonary, Critical Care, Sleep and Occupational Medicine
Indiana University School of Medicine
Indianapolis, Ind.
Term Ends June 2023

Deborah J. Levine, M.D.
Director of Pulmonary Hypertension Clinic
Medical Director of Inpatient and Outpatient Lung Transplantation
University of Texas Health Science Center
San Antonio, Texas
Term Ends June 2021

Lana Melendres-Groves, M.D.
Medical Director, Pulmonary Hypertension Program
Associate Professor, Dept. of Internal Medicine
Pulmonary & Critical Care Division
University of New Mexico
Albuquerque, N.M.
Term Ends June 2022

John J. Ryan, M.D., M.B., B.Ch., BAO
Co-Director, Pulmonary Hypertension Comprehensive Care Center
University of Utah
Salt Lake City, Utah
Term Ends June 2021

Jeffrey S. Sager, M.D., MSCE
Director, Cottage Pulmonary Hypertension Center
Santa Barbara Pulmonary Consultants
Santa Barbara, Calif.
Term Ends June 2022

Oksana A. Shlobin, M.D., FCCP
Director, Pulmonary Hypertension Program
Director of Education, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Associate Professor
Georgetown University School of Medicine
Virginia Commonwealth University School of Medicine
Term Ends June 2023

Thenappan Thenappan, M.D.
Associate Professor of Medicine, Cardiovascular Division
University of Minnesota
Minneapolis, Minn.
Term Ends June 2021

Corey E. Ventetuolo, M.D., M.S.
Assistant Professor of Medicine and Health Services, Policy, and Practice, The Warren Alpert Medical School of Brown University
Associate Director, Pulmonary Hypertension Center
Medical Director, Adult Extracorporeal Life Support Program
Director of Clinical Research, Pulmonary Division
Rhode Island Hospital
Providence, R.I.
Terms Ends June 2021

R. James White, M.D., Ph.D.
Professor of Medicine, Pharmacology & Physiology
University of Rochester Medical Center
Rochester, N.Y.
Term Ends June 2023

Timothy L. Williamson, M.D.
Associate Professor of Medicine
Director, Center for Pulmonary Arterial Hypertension
University of Kansas Medical Center
Kansas City, Kan.
Term Ends June 2023

Delphine Yung, M.D.
Associate Professor
Center for Clinical and Translational Research
Seattle Children’s Hospital
Seattle, Wash.
Term Ends June 2022

Liaisons

Nicole Reid, R.N., B.S.N.
Patient Liaison
Washington, D.C.
Term Ends June 2021

Cheri Abbott, R.N., CCRP
PH Professional Network Liaison
Chair-Elect, PH Professional Network
Clinical Research Program Coordinator
University of Colorado School of Medicine
Denver, Colo.
Terms Ends June 2022

Kimberly Jackson, R.N., B.S.N.
PH Professional Network Liaison
Chair-Elect, PH Professional Network
Nurse Cardiovascular Coordinator
University of Kentucky, Gill Heart Institute
Lexington, Ky.
Term Ends June 2024

SLC Distinguished Advisory Committee

David B. Badesch, M.D.
Professor of Medicine
Clinical Director, Pulmonary Hypertension Center
University of Colorado Health Sciences Center
Aurora, Colo.

Erika S. Berman Rosenzweig, M.D.
Professor of Pediatrics (in Medicine)
Columbia University Medical Center – New York Presbyterian Hospital
New York, N.Y.

Bruce Brundage, M.D.
Professor of Medicine Emeritus
David Geffen School of Medicine at UCLA
Bend, Ore.

Richard N. Channick, M.D.
Associate Professor of Medicine
Harvard Medical School
Director, Pulmonary Hypertension Program
Massachusetts General Hospital
Boston, Mass.

C. Gregory Elliott, M.D.
Professor of Medicine
University of Utah School of Medicine
Murray, Utah

Karen A. Fagan, M.D.
Chief of Pulmonology, Critical Care
Professor of Internal Medicine and Pharmacology
University of South Alabama
Mobile, Ala.

Michael D. McGoon, M.D.
Professor Emeritus of Medicine
Mayo Clinic
Rochester, Minn.

Vallerie V. McLaughlin, M.D.
Director, Pulmonary Hypertension Program
Kim A. Eagle, MD, Endowed Professor in Cardiovascular Medicine
University of Michigan CVC Cardiovascular Medicine
Ann Arbor, Mich.

John H. Newman, M.D.
Elsa S. Hanigan Professor of Pulmonary Medicine
Director, Pulmonary & Critical Care Fellowship Program
Vanderbilt University School of Medicine
Nashville, Tenn.